The Changing Transplant Landscape in the Era of Elexacaftor/Tezacaftor/Ivacaftor: A Word of Caution
Lung transplant recipients in the post-ETI era were more complex with high-risk characteristics and had worse post-transplant outcomes. This study highlights the importance of further investigation to better understand the impact of ETI on transplant referral patterns, recipient characteristics, and post-transplant outcomes in the CF population.
Authors
- Xiayi Ma (ORCID: https://orcid.org/0000-0003-3504-7637)
- Meghan Aversa (ORCID: https://orcid.org/0000-0002-7361-0024)
- Stephanie Y. Cheng (ORCID: https://orcid.org/0000-0003-2890-8451)
- Julie Semenchuk (ORCID: https://orcid.org/0000-0002-2933-2741)
- Cecilia Chaparro (ORCID: https://orcid.org/0000-0003-1674-375X)
- Anne L. Stephenson (ORCID: https://orcid.org/0000-0002-4529-5653)
- Jenna Sykes (ORCID: https://orcid.org/0000-0002-3282-9361)
- Elizabeth Tullis
- Eliza Tuff‐Gordon
Institutions
- St. Michael's Hospital (CA)
- University Health Network (CA)
- University of Toronto (CA)
- Cystic Fibrosis Canada (CA)
Publication Details
- Journal
- Clinical Transplantation
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1111/ctr.70317
- Citations
- 1
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 1.52